China Resources Pharmaceutical Group Limited
China Resources Pharmaceutical Group Limited (3320.HK) Stock Competitors & Peer Comparison
See (3320.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 3320.HK | HK$4.73 | -1.25% | 29.7B | 6.39 | HK$0.74 | +2.85% |
| 3692.HK | HK$33.72 | -1.11% | 204.4B | 30.94 | HK$1.09 | +1.09% |
| 2196.HK | HK$17.40 | -0.46% | 65.2B | 11.52 | HK$1.51 | +2.01% |
| 0874.HK | HK$15.83 | -0.44% | 39.3B | 7.57 | HK$2.09 | +5.53% |
| 1513.HK | HK$27.50 | -0.51% | 30.1B | 10.83 | HK$2.54 | +4.36% |
| 0867.HK | HK$10.99 | +0.09% | 26.8B | 15.48 | HK$0.71 | +2.97% |
| 0512.HK | HK$5.49 | +0.55% | 19.2B | 15.69 | HK$0.35 | N/A |
| 3933.HK | HK$8.96 | +1.36% | 17.7B | 7.06 | HK$1.27 | +6.35% |
| 0013.HK | HK$19.17 | +1.59% | 16.5B | 4.61 | HK$4.16 | N/A |
| 9989.HK | HK$4.44 | -0.67% | 15B | 14.80 | HK$0.30 | +6.12% |
Stock Comparison
3320.HK vs 3692.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 3692.HK has a market cap of 204.4B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 3692.HK trades at HK$33.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 3692.HK's P/E ratio is 30.94. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 3692.HK's ROE of +0.17%. Regarding short-term risk, 3320.HK is less volatile compared to 3692.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 3692.HK's competition here
3320.HK vs 2196.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 2196.HK has a market cap of 65.2B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 2196.HK trades at HK$17.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 2196.HK's P/E ratio is 11.52. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 2196.HK's ROE of +0.09%. Regarding short-term risk, 3320.HK is more volatile compared to 2196.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 2196.HK's competition here
3320.HK vs 0874.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 0874.HK has a market cap of 39.3B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 0874.HK trades at HK$15.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 0874.HK's P/E ratio is 7.57. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0874.HK's ROE of +0.08%. Regarding short-term risk, 3320.HK is less volatile compared to 0874.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 0874.HK's competition here
3320.HK vs 1513.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 1513.HK has a market cap of 30.1B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 1513.HK trades at HK$27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 1513.HK's P/E ratio is 10.83. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 1513.HK's ROE of +0.14%. Regarding short-term risk, 3320.HK is more volatile compared to 1513.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 1513.HK's competition here
3320.HK vs 0867.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 0867.HK has a market cap of 26.8B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 0867.HK trades at HK$10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 0867.HK's P/E ratio is 15.48. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0867.HK's ROE of +0.09%. Regarding short-term risk, 3320.HK is less volatile compared to 0867.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 0867.HK's competition here
3320.HK vs 0512.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 0512.HK has a market cap of 19.2B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 0512.HK trades at HK$5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 0512.HK's P/E ratio is 15.69. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0512.HK's ROE of +0.07%. Regarding short-term risk, 3320.HK is more volatile compared to 0512.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 0512.HK's competition here
3320.HK vs 3933.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 3933.HK has a market cap of 17.7B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 3933.HK trades at HK$8.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 3933.HK's P/E ratio is 7.06. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 3933.HK's ROE of +0.13%. Regarding short-term risk, 3320.HK is less volatile compared to 3933.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 3933.HK's competition here
3320.HK vs 0013.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 0013.HK has a market cap of 16.5B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 0013.HK trades at HK$19.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 0013.HK's P/E ratio is 4.61. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0013.HK's ROE of +0.37%. Regarding short-term risk, 3320.HK is more volatile compared to 0013.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 0013.HK's competition here
3320.HK vs 9989.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 9989.HK has a market cap of 15B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 9989.HK trades at HK$4.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 9989.HK's P/E ratio is 14.80. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 9989.HK's ROE of +0.03%. Regarding short-term risk, 3320.HK is more volatile compared to 9989.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 9989.HK's competition here
3320.HK vs 1558.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 1558.HK has a market cap of 14B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 1558.HK trades at HK$15.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 1558.HK's P/E ratio is 26.47. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 1558.HK's ROE of +0.06%. Regarding short-term risk, 3320.HK is less volatile compared to 1558.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 1558.HK's competition here
3320.HK vs 1681.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 1681.HK has a market cap of 12.2B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 1681.HK trades at HK$14.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 1681.HK's P/E ratio is 9.96. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 1681.HK's ROE of +0.24%. Regarding short-term risk, 3320.HK is more volatile compared to 1681.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 1681.HK's competition here
3320.HK vs 2627.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 2627.HK has a market cap of 10.6B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 2627.HK trades at HK$29.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 2627.HK's P/E ratio is -44.42. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 2627.HK's ROE of -1.43%. Regarding short-term risk, 3320.HK is less volatile compared to 2627.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 2627.HK's competition here
3320.HK vs 6185.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 6185.HK has a market cap of 9.8B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 6185.HK trades at HK$28.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 6185.HK's P/E ratio is 233.83. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 6185.HK's ROE of -0.00%. Regarding short-term risk, 3320.HK is less volatile compared to 6185.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 6185.HK's competition here
3320.HK vs 0719.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 0719.HK has a market cap of 9.4B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 0719.HK trades at HK$6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 0719.HK's P/E ratio is 13.89. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0719.HK's ROE of +0.05%. Regarding short-term risk, 3320.HK is more volatile compared to 0719.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 0719.HK's competition here
3320.HK vs 0460.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 0460.HK has a market cap of 9.4B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 0460.HK trades at HK$1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 0460.HK's P/E ratio is 52.00. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0460.HK's ROE of +0.04%. Regarding short-term risk, 3320.HK is more volatile compared to 0460.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 0460.HK's competition here
3320.HK vs 2575.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 2575.HK has a market cap of 9.3B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 2575.HK trades at HK$17.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 2575.HK's P/E ratio is -29.34. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 2575.HK's ROE of -0.54%. Regarding short-term risk, 3320.HK is less volatile compared to 2575.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 2575.HK's competition here
3320.HK vs 0570.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 0570.HK has a market cap of 8.1B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 0570.HK trades at HK$1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 0570.HK's P/E ratio is -20.00. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0570.HK's ROE of -0.02%. Regarding short-term risk, 3320.HK is more volatile compared to 0570.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 0570.HK's competition here
3320.HK vs 2005.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 2005.HK has a market cap of 7B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 2005.HK trades at HK$2.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 2005.HK's P/E ratio is 14.81. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 2005.HK's ROE of +0.06%. Regarding short-term risk, 3320.HK is more volatile compared to 2005.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 2005.HK's competition here
3320.HK vs 2877.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 2877.HK has a market cap of 6.4B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 2877.HK trades at HK$8.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 2877.HK's P/E ratio is 5.81. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 2877.HK's ROE of +0.12%. Regarding short-term risk, 3320.HK is more volatile compared to 2877.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 2877.HK's competition here
3320.HK vs 2552.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 2552.HK has a market cap of 3.2B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 2552.HK trades at HK$3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 2552.HK's P/E ratio is 2.59. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 2552.HK's ROE of +1.07%. Regarding short-term risk, 3320.HK is less volatile compared to 2552.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 2552.HK's competition here
3320.HK vs 2561.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 2561.HK has a market cap of 2.6B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 2561.HK trades at HK$24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 2561.HK's P/E ratio is -8.54. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 2561.HK's ROE of -0.25%. Regarding short-term risk, 3320.HK is less volatile compared to 2561.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 2561.HK's competition here
3320.HK vs 6896.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 6896.HK has a market cap of 2.6B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 6896.HK trades at HK$3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 6896.HK's P/E ratio is 8.97. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 6896.HK's ROE of +0.19%. Regarding short-term risk, 3320.HK is more volatile compared to 6896.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 6896.HK's competition here
3320.HK vs 2633.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 2633.HK has a market cap of 2.3B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 2633.HK trades at HK$1.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 2633.HK's P/E ratio is 7.73. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 2633.HK's ROE of +0.13%. Regarding short-term risk, 3320.HK is less volatile compared to 2633.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 2633.HK's competition here
3320.HK vs 2161.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 2161.HK has a market cap of 2B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 2161.HK trades at HK$2.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 2161.HK's P/E ratio is 8.93. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 2161.HK's ROE of +0.20%. Regarding short-term risk, 3320.HK is more volatile compared to 2161.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 2161.HK's competition here
3320.HK vs 1061.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 1061.HK has a market cap of 1.7B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 1061.HK trades at HK$2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 1061.HK's P/E ratio is 5.34. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 1061.HK's ROE of +0.14%. Regarding short-term risk, 3320.HK is less volatile compared to 1061.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 1061.HK's competition here
3320.HK vs 2348.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 2348.HK has a market cap of 1.7B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 2348.HK trades at HK$1.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 2348.HK's P/E ratio is 6.94. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 2348.HK's ROE of +0.06%. Regarding short-term risk, 3320.HK is more volatile compared to 2348.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 2348.HK's competition here
3320.HK vs 8049.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 8049.HK has a market cap of 1.3B. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 8049.HK trades at HK$2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 8049.HK's P/E ratio is 5.76. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 8049.HK's ROE of +0.12%. Regarding short-term risk, 3320.HK is more volatile compared to 8049.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 8049.HK's competition here
3320.HK vs 1349.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 1349.HK has a market cap of 894.2M. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 1349.HK trades at HK$2.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 1349.HK's P/E ratio is -15.47. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 1349.HK's ROE of -0.07%. Regarding short-term risk, 3320.HK is more volatile compared to 1349.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 1349.HK's competition here
3320.HK vs 1652.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 1652.HK has a market cap of 805.8M. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 1652.HK trades at HK$1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 1652.HK's P/E ratio is -54.50. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 1652.HK's ROE of -0.03%. Regarding short-term risk, 3320.HK is more volatile compared to 1652.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 1652.HK's competition here
3320.HK vs 0239.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 0239.HK has a market cap of 757.3M. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 0239.HK trades at HK$2.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 0239.HK's P/E ratio is 8.38. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0239.HK's ROE of +0.13%. Regarding short-term risk, 3320.HK is more volatile compared to 0239.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 0239.HK's competition here
3320.HK vs 0503.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 0503.HK has a market cap of 750.6M. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 0503.HK trades at HK$1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 0503.HK's P/E ratio is 13.77. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0503.HK's ROE of +0.07%. Regarding short-term risk, 3320.HK is less volatile compared to 0503.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 0503.HK's competition here
3320.HK vs 3737.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 3737.HK has a market cap of 658.1M. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 3737.HK trades at HK$0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 3737.HK's P/E ratio is 39.00. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 3737.HK's ROE of +0.02%. Regarding short-term risk, 3320.HK is less volatile compared to 3737.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 3737.HK's competition here
3320.HK vs 0950.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 0950.HK has a market cap of 641.8M. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 0950.HK trades at HK$1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 0950.HK's P/E ratio is 6.81. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0950.HK's ROE of +0.05%. Regarding short-term risk, 3320.HK is less volatile compared to 0950.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 0950.HK's competition here
3320.HK vs 1011.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 1011.HK has a market cap of 393.9M. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 1011.HK trades at HK$0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 1011.HK's P/E ratio is -12.00. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 1011.HK's ROE of +0.09%. Regarding short-term risk, 3320.HK is more volatile compared to 1011.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 1011.HK's competition here
3320.HK vs 1466.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 1466.HK has a market cap of 386.7M. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 1466.HK trades at HK$0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 1466.HK's P/E ratio is 50.00. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 1466.HK's ROE of +0.06%. Regarding short-term risk, 3320.HK is less volatile compared to 1466.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 1466.HK's competition here
3320.HK vs 0897.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 0897.HK has a market cap of 351M. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 0897.HK trades at HK$0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 0897.HK's P/E ratio is -31.50. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0897.HK's ROE of -0.01%. Regarding short-term risk, 3320.HK is more volatile compared to 0897.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 0897.HK's competition here
3320.HK vs 8329.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 8329.HK has a market cap of 196.3M. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 8329.HK trades at HK$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 8329.HK's P/E ratio is -3.90. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 8329.HK's ROE of -0.05%. Regarding short-term risk, 3320.HK is less volatile compared to 8329.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 8329.HK's competition here
3320.HK vs 0455.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 0455.HK has a market cap of 195.7M. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 0455.HK trades at HK$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 0455.HK's P/E ratio is -3.03. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0455.HK's ROE of -0.15%. Regarding short-term risk, 3320.HK is more volatile compared to 0455.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 3320.HK.Check 0455.HK's competition here
3320.HK vs 0858.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 0858.HK has a market cap of 193.8M. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 0858.HK trades at HK$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 0858.HK's P/E ratio is -0.54. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0858.HK's ROE of -0.30%. Regarding short-term risk, 3320.HK is less volatile compared to 0858.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 0858.HK's competition here
3320.HK vs 8622.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 8622.HK has a market cap of 159.8M. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 8622.HK trades at HK$0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 8622.HK's P/E ratio is -31.00. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 8622.HK's ROE of -0.10%. Regarding short-term risk, 3320.HK is less volatile compared to 8622.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 8622.HK's competition here
3320.HK vs 0911.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 0911.HK has a market cap of 123.7M. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 0911.HK trades at HK$0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 0911.HK's P/E ratio is 18.25. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 0911.HK's ROE of +0.01%. Regarding short-term risk, 3320.HK is less volatile compared to 0911.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 0911.HK's competition here
3320.HK vs 1498.HK Comparison May 2026
3320.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3320.HK stands at 29.7B. In comparison, 1498.HK has a market cap of 123.5M. Regarding current trading prices, 3320.HK is priced at HK$4.73, while 1498.HK trades at HK$0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3320.HK currently has a P/E ratio of 6.39, whereas 1498.HK's P/E ratio is -3.69. In terms of profitability, 3320.HK's ROE is +0.08%, compared to 1498.HK's ROE of -0.30%. Regarding short-term risk, 3320.HK is less volatile compared to 1498.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3320.HK.Check 1498.HK's competition here